Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | KDM1A | O60341 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HTR7 | P34969 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30800480 | 0.87 | PIK3CD (0.50) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL6960632 | 0.84 | PIK3CD (0.66) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL23823660 | 0.83 | CYP1A2 (0.64) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL26023055 | 0.79 | PIK3CD (0.55) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL18711510 | 0.79 | PIK3CD (0.70) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL23689771 | 0.78 | PIK3CD (0.53) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL23986518 | 0.78 | PIK3CD (0.58) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL11932577 | 0.77 | PIK3CD (0.61) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL2619225 | 0.77 | CYP1A2 (0.56) | PIK3CDCYP1A2TDP1DRD3HRH3 | |
| SCHEMBL297533 | 0.77 | CYP1A2 (0.56) | PIK3CDCYP1A2TDP1DRD3HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIV POITIERS (FR) | 2026-05-07 | — | — | US | disclosed |
| EP-4598903-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | Université de Poitiers (FR) | 2025-08-13 | — | — | EP | disclosed |
| CN-120035579-A | Process for fluorinating and/or cyclizing an amino alkene or alkyne in a continuous flow and apparatus for carrying out the process | 普瓦捷大学 | 2025-05-23 | — | — | CN | disclosed |
| WO-2024074501-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | UNIVERSITE DE POITIERS (FR) | 2024-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125349-A1 | PROCESS FOR THE FLUORINATION AND/OR CYCLIZATION OF AN AMINO ALKENE OR ALKYNE IN A CONTINUOUS STREAM AND FACILITY FOR PERFORMING THE PROCESS | FIBP, FGB, SUB1 | PIK3CD 1639/4885CYP1A2 1163/4885TDP1 3633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.